EyePoint Pharmaceuticals
EYPT
#5308
Rank
NZ$2.44 B
Marketcap
NZ$29.53
Share price
-4.15%
Change (1 day)
95.47%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$89.05 Million

According to EyePoint Pharmaceuticals 's latest financial reports the company's total liabilities are NZ$89.05 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

EyePoint Pharmaceuticals - Total liabilities on balance sheet (from 2003 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$0.14 B3.43%
2023-12-31NZ$0.14 B6.22%
2022-12-31NZ$0.13 B14.39%
2021-12-31NZ$0.11 B14.03%
2020-12-31NZ$0.10 B5.66%
2019-12-31NZ$95.98 M
2018-06-30NZ$88.57 M1114.11%
2017-06-30NZ$7.29 M-51.52%
2016-06-30NZ$15.04 M13.49%
2015-06-30NZ$13.25 M49.98%
2014-06-30NZ$8.84 M-19.98%
2013-06-30NZ$11.04 M27.38%
2012-06-30NZ$8.67 M-25.77%
2011-06-30NZ$11.68 M-18.95%
2010-06-30NZ$14.41 M-31.85%
2009-06-30NZ$21.15 M-37.39%
2008-06-30NZ$33.78 M37.03%
2007-06-30NZ$24.65 M-66.73%
2006-06-30NZ$74.11 M448.49%
2005-06-30NZ$13.51 M541.68%
2004-06-30NZ$2.1 M108.36%
2003-06-30NZ$1.01 M
2001-06-30NZ$0.35 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NRC Health
NRC
NZ$0.20 B 135.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
NZ$5.44 M-93.89% Bahamas